BACKGROUND: Repeated Chlamydia trachomatis infections are common among young sexually active women. The relative frequency of reinfection and antibiotic treatment failure is undefined. METHODS: Adolescent women enrolled in a longitudinal cohort had behavioral and sexually transmitted infection assessments performed every 3 months, including amplification tests for C. trachomatis, ompA genotyping, and interviews and diary entries to document sex partner-specific coitus and event-specific condom use. Repeated infections were classified as reinfection or treatment failure by use of an algorithm. All infections for which treatment outcomes were known were used to estimate the effectiveness of antibiotic use. RESULTS: We observed 478 episodes of infection among 210 study participants; 176 women remained uninfected. The incidence rate was 34 episodes/100 woman-years. Of the women who were infected, 121 experienced 1 repeated infections, forming 268 episode pairs; 183 pairs had complete data available and were classified using the algorithm. Of the repeated infections, 84.2% were definite, probable, or possible reinfections; 13.7% were probable or possible treatment failures; and 2.2% persisted without documented treatment. For 318 evaluable infections, we estimated 92.2% effectiveness of antibiotic use. CONCLUSIONS: Most repeated chlamydial infections in this high-incidence cohort were reinfections, but repeated infections resulting from treatment failures occurred as well. Our results have implications for male screening and partner notification programs and suggest the need for improved antibiotic therapies.
BACKGROUND: Repeated Chlamydia trachomatis infections are common among young sexually active women. The relative frequency of reinfection and antibiotic treatment failure is undefined. METHODS: Adolescent women enrolled in a longitudinal cohort had behavioral and sexually transmitted infection assessments performed every 3 months, including amplification tests for C. trachomatis, ompA genotyping, and interviews and diary entries to document sex partner-specific coitus and event-specific condom use. Repeated infections were classified as reinfection or treatment failure by use of an algorithm. All infections for which treatment outcomes were known were used to estimate the effectiveness of antibiotic use. RESULTS: We observed 478 episodes of infection among 210 study participants; 176 women remained uninfected. The incidence rate was 34 episodes/100 woman-years. Of the women who were infected, 121 experienced 1 repeated infections, forming 268 episode pairs; 183 pairs had complete data available and were classified using the algorithm. Of the repeated infections, 84.2% were definite, probable, or possible reinfections; 13.7% were probable or possible treatment failures; and 2.2% persisted without documented treatment. For 318 evaluable infections, we estimated 92.2% effectiveness of antibiotic use. CONCLUSIONS: Most repeated chlamydial infections in this high-incidence cohort were reinfections, but repeated infections resulting from treatment failures occurred as well. Our results have implications for male screening and partner notification programs and suggest the need for improved antibiotic therapies.
Authors: João P Gomes; William J Bruno; Alexandra Nunes; Nicole Santos; Carlos Florindo; Maria J Borrego; Deborah Dean Journal: Genome Res Date: 2006-11-07 Impact factor: 9.043
Authors: Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes Journal: N Engl J Med Date: 2005-02-17 Impact factor: 91.245
Authors: Barbara Van Der Pol; James A Williams; Donald P Orr; Byron E Batteiger; J Dennis Fortenberry Journal: J Infect Dis Date: 2005-11-08 Impact factor: 5.226
Authors: C J McDonald; J M Overhage; W M Tierney; P R Dexter; D K Martin; J G Suico; A Zafar; G Schadow; L Blevins; T Glazener; J Meeks-Johnson; L Lemmon; J Warvel; B Porterfield; J Warvel; P Cassidy; D Lindbergh; A Belsito; M Tucker; B Williams; C Wodniak Journal: Int J Med Inform Date: 1999-06 Impact factor: 4.046
Authors: Marcia L Shew; J Dennis Fortenberry; Wanzhu Tu; Beth E Juliar; Byron E Batteiger; Brahim Qadadri; Darron R Brown Journal: Arch Pediatr Adolesc Med Date: 2006-02
Authors: Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville Journal: Infect Immun Date: 2012-03-19 Impact factor: 3.441
Authors: S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston Journal: Clin Microbiol Rev Date: 2015-10 Impact factor: 26.132
Authors: Janneke C M Heijne; Christian L Althaus; Sereina A Herzog; Mirjam Kretzschmar; Nicola Low Journal: J Infect Dis Date: 2010-12-24 Impact factor: 5.226
Authors: Patricia J Kissinger; Scott White; Lisa E Manhart; Jane Schwebke; Stephanie N Taylor; Leandro Mena; Christine M Khosropour; Larissa Wilcox; Norine Schmidt; David H Martin Journal: Sex Transm Dis Date: 2016-10 Impact factor: 2.830
Authors: Romina Barral; Ruchi Desai; Xiaojing Zheng; Lauren C Frazer; Gina S Sucato; Catherine L Haggerty; Catherine M O'Connell; Matthew A Zurenski; Toni Darville Journal: J Reprod Immunol Date: 2014-02-01 Impact factor: 4.054
Authors: Jennifer L Reed; Jill S Huppert; Regina G Taylor; Gordon L Gillespie; Terri L Byczkowski; Jessica A Kahn; Evaline A Alessandrini Journal: J Adolesc Health Date: 2014-06-21 Impact factor: 5.012